Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Completed1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
recruiting133%
terminated133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Infant Formula in Infants and Children With Cow's Milk Allergy

NCT06456541
terminatednot_applicable

Extensively Hydrolyzed Infant Formula in Infants and Children With Cow's Milk Allergy

NCT04910373
completednot_applicable

Formula for Children With Cow's Milk Allergy

NCT02317952

Clinical Trials (3)

Showing 3 of 3 trials
NCT06456541Not Applicable

Infant Formula in Infants and Children With Cow's Milk Allergy

Recruiting
NCT04910373Not Applicable

Extensively Hydrolyzed Infant Formula in Infants and Children With Cow's Milk Allergy

Terminated
NCT02317952Not Applicable

Formula for Children With Cow's Milk Allergy

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3